Valuation: Organoidsciences Ltd.

Market Cap 43.47B 29.96M 26.32M 24.57M 22.55M 42.21M 2.87B 43.25M 291M 114M 1.42B 112M 110M 4.91B P/E 2024 *
-
P/E 2025 -15.2x
Enterprise Value 31.9B 21.99M 19.32M 18.04M 16.55M 30.98M 2.11B 31.75M 214M 83.64M 1.04B 82.56M 80.76M 3.6B EV / Sales 2024 *
-
EV / Sales 2025 99.9x
Free-Float
57.27%
Yield 2024 *
-
Yield 2025 -
1 day-11.76%
1 week-11.65%
Current month-31.61%
1 month-25.68%
3 months-71.24%
6 months-80.47%
Current year-82.77%
1 week 6,600
Extreme 6600
8,290
1 month 6,600
Extreme 6600
10,360
Current year 6,600
Extreme 6600
39,200
1 year 6,600
Extreme 6600
48,500
3 years 6,600
Extreme 6600
52,000
5 years 6,600
Extreme 6600
52,000
10 years 6,600
Extreme 6600
52,000
Manager TitleAgeSince
Chief Executive Officer 46 -
Chief Executive Officer 62 2026-01-01
Chief Tech/Sci/R&D Officer 41 -
Director TitleAgeSince
Director/Board Member - 2025-03-26
Director/Board Member 69 2026-01-01
Director/Board Member 72 2026-01-01
Date Insider Type Main position Quantity % Market Cap.
5/14/25 Others

Chief Executive Officer

1,670,000 -
5/14/25 Others 30,000 -
Change 5-day change 1-year change 3-year change Capi.($)
-11.76%-11.65%-79.66% - 33.86M
+2.61%+7.16%-0.93%+13.78% 47.88B
-0.28%-0.52%+391.98%+593.64% 39.09B
-0.39%+2.52%+7.27%+53.10% 36.75B
+1.51%+23.84%+26.36%+9.87% 40.55B
+1.47%+4.90%+6.48%+43.52% 27.96B
-0.33%+0.81% - - 16.77B
+2.84%+10.75%+30.58%+131.03% 15.94B
+0.18%-2.75%+3.22%+9.68% 13.55B
+0.72%+8.79%-1.74%-27.61% 13.81B
Average -0.27%+2.82%+42.62%+103.38% 25.23B
Weighted average by Cap. +0.99%+5.06%+73.44%+124.28%

Financials

2024 2025
Net sales 1.95B 1.35M 1.18M 1.1M 1.01M 1.9M 129M 1.94M 13.09M 5.12M 63.81M 5.05M 4.94M 221M 2.41B 1.66M 1.46M 1.36M 1.25M 2.34M 159M 2.39M 16.13M 6.31M 78.62M 6.23M 6.09M 272M
Net income -11.25B -7.75M -6.81M -6.36M -5.83M -10.92M -742M -11.19M -75.39M -29.48M -367M -29.1M -28.47M -1.27B -15.37B -10.59M -9.31M -8.69M -7.97M -14.92M -1.01B -15.29M -103M -40.29M -502M -39.77M -38.9M -1.74B
Net Debt -8.11B -5.59M -4.91M -4.58M -4.21M -7.87M -535M -8.07M -54.34M -21.25M -265M -20.98M -20.52M -916M -11.56B -7.97M -7M -6.54M -6M -11.23M -763M -11.5M -77.5M -30.31M -378M -29.92M -29.27M -1.31B
Logo Organoidsciences Ltd.
OrganoidSciences Ltd is a Korea-based company primarily engaged in the development of regenerative therapies and provision of new material evaluation solutions. The Company primarily provides an organoid-based new material evaluation solution under the name of ODISEI to predict the effects of various new materials such as new drugs, foods and cosmetics when applied to the human body. In addition, the Company develops organoid-based regenerative therapies that directly regenerate tissues by engrafting on damaged areas. The Company is also engaged in the sale of intestinal organoid therapeutics, salivary gland organoid regenerative therapeutics, and other research reagents.
Employees
-
Date Price Change Volume
26-07-28 6,600.00 -11.76% 41,809
26-07-28 ₩7,480.00 -9.22% 23,488
26-07-27 ₩8,240.00 +5.91% 20,299
26-07-24 ₩7,780.00 +1.70% 22,051
26-07-23 ₩7,650.00 +2.41% 18,069
  1. Stock Market
  2. Stocks
  3. A476040 Stock